Abstract
To find a novel marker for identifying patients at high-risk for endothelial dysfunction among patients with atherosclerosis, we examined the correlation between mRNA levels of Fas ligand (FasL), an apoptosis-inducing factor, in circulating leukocytes and clinical parameters in these patients. FasL mRNA levels of circulating leukocytes were measured with the TaqMan-PCR method. A negative correlation was observed between brachial artery flow-mediated dilatation (%FMD) and FasL mRNA levels of leukocytes in hyperlipidemic but not in non-hyperlipidemic patients. %FMD was more impaired in patients with a high level of FasL mRNA than in those with a low level of FasL mRNA. Interestingly, the improvement of %FMD by treatment with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (simvastatin) was greater in the group showing a decrease in FasL mRNA than in the group with no such decrease. Additionally, simvastatin suppressed the FasL mRNA expression in leukocytes and decreased plasma oxidized low-density lipoprotein (OxLDL) levels. Furthermore, the supernatant of cultured leukocytes from hyperlipidemic patients induced cell death in Jurkat T cells, which was neutralized by an antibody against FasL. These findings suggest that high FasL mRNA expression in circulating leukocytes may be a marker of high-risk for endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients. This information may provide a novel basis for targeting of statin therapy in patients with vulnerable plaques.
Similar content being viewed by others
Article PDF
References
Naghavi M, Libby P, Falk E, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772–1778.
Kario K, McEwen BS, Pickering TG : Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res 2003; 26: 355–367.
Hutter R, Valdiviezo C, Sauter BV, et al: Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 2004; 109: 2001–2008.
Sata M, Hirata Y, Nagai R : Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Hypertens Res 2002; 25: 577–582.
Durand E, Scoazec A, Lafont A, et al: In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004; 109: 2503–2506.
Nagata S : Apoptosis by death factor. Cell 1997; 88: 355–365.
Sata M, Walsh K : Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem 1998; 273: 33103–33106.
Shimizu M, Fukuo K, Nagata S, et al: Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. J Am Coll Cardiol 2002; 39: 585–590.
Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. Circulation 2003; 108: 1506–1513.
Vaughan CJ, Murphy MB, Buckley BM : Statins do more than just lower cholesterol. Lancet 1996; 348: 1079–1082.
Wolfrum S, Jensen KS, Liao JK : Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003; 23: 729–736.
Minami M, Atarashi K, Ishiyama A, Hirata Y, Goto A, Omata M : Effects of cholesterol-lowering therapy on pressor hyperreactivity to stress in hypercholesterolemic patients. Hypertens Res 2003; 26: 273–280.
Dimmeler S, Haendeler J, Nehls M, Zeiher AM : Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)−like and cysteine protease protein (CPP)-32−like proteases. J Exp Med 1997; 185: 601–607.
Guijarro C, Blanco-Colio LM, Ortego M, et al: 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998; 83: 490–500.
Weis M, Heeschen C, Glassford AJ, Cooke JP : Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739–745.
Fujii K, Abe I, Ohya Y, et al: Risk factors for the progression of early carotid atherosclerosis in a male working population. Hypertens Res 2003; 26: 465–471.
Sumino H, Ichikawa S, Kasama S, et al: Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Hypertens Res 2005; 28: 579–584.
Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T : Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471–477.
Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A : Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: 475–480.
Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–1115.
Moriguchi J, Itoh H, Harada S, et al: Low frequency regular exercise improves flow-mediated dilatation of subjects with mild hypertension. Hypertens Res 2005; 28: 315–321.
Benjamin EJ, Larson MG, Keyes MJ, et al: Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004; 109: 613–619.
Mosmann T : Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.
Diez-Roux G, Lang RA : Macrophages induce apoptosis in normal cells in vivo. Development 1997; 124: 3633–3638.
Asai K, Kudej RK, Shen YT, et al: Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 2000; 20: 1493–1499.
Liao JK, Shin WS, Lee WY, Clark SL : Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319–324.
Ohara Y, Peterson TE, Harrison DG : Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546–2551.
Aprahamian T, Rifkin I, Bonegio R, et al: Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004; 199: 1121–1131.
Schonbeck U, Gerdes N, Varo N, et al: Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 2002; 106: 2888–2893.
Eto M, Kozai T, Cosentino F, Joch H, Luscher TF : Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 2002; 105: 1756–1759.
Okura Y, Takao M, Zhang B, Nakashima Y, Saku K : Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004; 27: 723–729.
Ridker PM, Rifai N, Clearfield M, et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959–1965.
Hozawa A, Ohmori K, Kuriyama S, et al: C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens Res 2004; 27: 955–961.
Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T : Caspase 1−independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998; 4: 1287–1292.
Chang MK, Binder CJ, Miller YI, et al: Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200: 1359–1370.
Kang SM, Schneider DB, Lin Z, et al: Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997; 3: 738–743.
Allison J, Georgiou HM, Strasser A, Vaux DL : Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci U S A 1997; 94: 3943–3947.
Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A : Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 2001; 167: 6217–6224.
Sato T, Machida T, Takahashi S, et al: Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 2004; 173: 285–296.
Medan D, Wang L, Toledo D, et al: Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J Cell Physiol 2005; 203: 78–84.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotani, N., Fukuo, K., Yasuda, O. et al. Fas Ligand mRNA Levels of Circulating Leukocytes Reflect Endothelial Dysfunction in Hyperlipidemic but Not in Non-Hyperlipidemic Patients. Hypertens Res 29, 217–225 (2006). https://doi.org/10.1291/hypres.29.217
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.217
Keywords
This article is cited by
-
Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction
Hypertension Research (2009)